Dr Aris Angelis is Secretery General for Strategic Planning at Greek Ministry of Health, reporting to the Minister of Health. Among his responsibilities include all aspects of pharmaceutical policy and regulation. Positions of responsibility at EU level include being co-chair of the Critical Medicines Alliance, member of EMA’s Committee for Medicinal Products for Human Use (CHMP) and member of OECD’s Health Committee.
Before taking on the new General Secretariat for Strategic Planning, Dr Aris Angelis was Assistant Professor of Health Economics in the Department of Health Services Research and Policy at the London School of Hygiene & Tropical Medicine (LSHTM), where he remains a Visiting Associate Professor. Before joining LSHTM, Dr Angelis was a Research Fellow and a Guest Teacher at the Department of Health Policy at the London School of Economics and Political Science (LSE).
Dr Angelis received his Doctor of Philosophy (PhD) in Health Policy and Economics from the LSE. He also holds an MSc in International Health Policy from the LSE, an MSc in Biopharmacy from King’s College London and a BSc in Biochemistry from Imperial College London.
In the past, Dr Angelis has undertaken contracted research, training and advisory work for the European Commission, the World Health Organization and national Ministries of Health, including the UK Department of Health and Social Care. He has published numerous research papers and studies in leading academic peer reviewed journals.
